IPG PHOTONICS CORP (IPGP) - Dilution Analysis

10-Q filing | 42.2M shares outstanding

10-Q filing | 42.2M shares outstanding

10-Q filing | 42.5M shares outstanding

10-Q filing | 42.6M shares outstanding

10-K filing | 44.3M shares outstanding

10-Q filing | 43.8M shares outstanding

10-Q filing | 44.9M shares outstanding

10-Q filing | 46.0M shares outstanding

10-K filing | 47.2M shares outstanding

10-Q filing | 47.2M shares outstanding

10-Q filing | 47.3M shares outstanding

8-K filing: Agnes Tang, a director of the Company, adopted a pre-arranged trading plan under Rule 10b5-1 to sell up to 900 shares of the Company's stock over a period ending in March 2024, subject to market prices and minimum price thresholds.

8-K filing: IPG Photonics Corporation filed an amendment to its Amended and Restated Certificate of Incorporation to eliminate monetary liability of certain executive officers for breaches of their duty of care. Certain directors and officers adopt Rule 10b5-1 trading plans, with Dr. Eugene Scherbakov, CEO and Director, adopting a plan to sell up to 13,000 shares.

10-Q filing | 47.5M shares outstanding

8-K filing: Directors and officers of IPG Photonics Corporation adopt Rule 10b5-1 trading plans for pre-arranged sales of company securities; Mr. Eric Meurice plans to sell up to 9,423 shares and Dr. Alexander Ovtchinnikov plans to sell up to 16,237 shares.

10-K filing | 50.8M shares outstanding

8-K filing: Certain insiders of the Company adopted pre-arranged trading plans (each, a "Plan") designed to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, and the Company's policies regarding stock transactions. The Valentin Gapontsev Trust I, II, and III plans provide for the sale of up to 165,000, 30,000, and 27,500 shares respectively over a period ending December 2023.

10-Q filing | 51.6M shares outstanding

8-K filing: Dr. Eugene A. Scherbakov, Director and Chief Executive Officer of IPG Photonics Corporation, adopted a Rule 10b5-1 trading plan to sell up to 3,000 shares of the company's stock, including shares acquired upon exercise of stock options, over a period ending February 2023, subject to minimum price thresholds.

10-Q filing | 51.7M shares outstanding

8-K filing: Insiders of IPG Photonics Corporation adopted pre-arranged trading plans under Rule 10b5-1 to sell shares of the company's stock on the open market.

10-Q filing | 52.8M shares outstanding

10-K filing | 53.4M shares outstanding

8-K filing: Thomas Burgomaster, Vice President, Corporate Controller, adopted a Rule 10b5-1 trading plan for the sale of up to 6,220 shares of IPG Photonics Corporation stock over a period ending in July 2022.

10-Q filing | 53.4M shares outstanding

10-Q filing | 53.5M shares outstanding

10-Q filing | 53.5M shares outstanding

8-K filing: Directors and officers of IPG Photonics adopt pre-arranged trading plans under Rule 10b5-1 for the sale of company securities.

10-K filing | 53.8M shares outstanding

8-K filing: Certain directors and officers of IPG Photonics Corporation adopted pre-arranged trading plans under Rule 10b5-1 for the sale of company securities. Mr. Timothy P.V. Mammen, Chief Financial Officer, plans to sell up to 16,125 shares, and Dr. George BuAbbud, Vice President of Telecommunications Product, plans to sell up to 5,339 shares, both over a period ending June 2021.

8-K filing: Certain directors and officers of IPG Photonics Corporation adopt pre-arranged trading plans (10b5-1) for the sale of company securities.

10-Q filing | 53.1M shares outstanding

8-K filing: Certain directors and officers of IPG Photonics Corporation adopted pre-arranged trading plans under Rule 10b5-1 for the sale of company securities.

10-Q filing | 53.0M shares outstanding

8-K filing: Dr. Eugene A. Scherbakov, Director, Chief Operating Officer, Managing Director of IPG Laser GmbH, and Senior Vice President of Europe, adopted a 10b5-1 trading plan to sell up to 3,000 shares of IPG Photonics Corporation over a period ending February 2021.

8-K filing: Mr. Thomas Burgomaster, Chief Accounting Officer of the Company, adopted a Rule 10b5-1 trading plan to sell up to 18,492 shares of company stock, including shares acquired upon exercise of stock options, on the open market at prevailing market prices, subject to minimum price thresholds, over a period ending June 22, 2021, unless terminated sooner in certain circumstances.

10-Q filing | 53.1M shares outstanding

10-K filing | 53.1M shares outstanding